_ajanta-pharma-approves-315-crore-share-buyback-at-1425-apiece-via-tender-offer-124-midcap-radar-preview-1.jpg "Ajanta Pharma Approves ₹315 Crore Share Buyback At ₹1,425 Apiece Via Tender Offer | Midcap Radar from ajanta pharmacy Video Screenshot Preview 1")
Gallery_ajanta-pharma-approves-315-crore-share-buyback-at-1425-apiece-via-tender-offer-124-midcap-radar-preview-3.jpg "Ajanta Pharma Approves ₹315 Crore Share Buyback At ₹1,425 Apiece Via Tender Offer | Midcap Radar from ajanta pharmacy Video Screenshot Preview 3")
Gallery_ajanta-pharma-approves-315-crore-share-buyback-at-1425-apiece-via-tender-offer-124-midcap-radar-preview-hqdefault.jpg "Ajanta Pharma Approves ₹315 Crore Share Buyback At ₹1,425 Apiece Via Tender Offer | Midcap Radar from ajanta pharmacy Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 51 seconds
👁 View: 937 times
Play Audio:👁 View: 937 times
Description:
CNBC-TV18
CNBC-TV18
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_alkhidmat-banoqabil-pharmacist-test.webp "Alkhidmat Karachi conducted the Aptitude Test for its Bano Qabil Pharmacist training program on Saturday, January 20, 2024. More than 500 aspirants who had registered themselves for the program attended the test which was held at a local hall. Present at the event were Executive Director Alkhidmat Karachi Rashid Qureishi, Director Pharmacy Services Syed Jamshed Ahmed and other senior officials. Speaking on the occasion, Ameer Jamaat-e-Islami Hafiz Naeem ur Rehman said that the Bano Qabil program was intended to solve a huge problem that Karachi’s youth are facing, namely unemployment.")
_ajanta-pharma-buyback-2024124-profit-calculation-124-ajanta-pharma-share-news-124-latest-buyback-news.webp "Yogesh Mantri")
⏲ 14 minutes 36 seconds 👁 2.2K
_top-2-pharma-midcap-stocks-124-ca-rachana-ranade.webp "CA Rachana Phadke Ranade")
_ajanta-pharma-share-news-today-ajanta-pharma-share-news-124-ajanta-pharma-share-124-26th-april-2024.webp "Dark Trading View")
⏲ 2 minutes 6 seconds 👁 228
_ajanta-pharma-ltd-q4-fy2023-24-earnings-conference-call.webp "AlphaStreet India")
_ajanta-pharma-what-makes-it-special.webp "VP Europe")
_ajanta-pharma-approves-315-crore-share-buyback-at-1425-apiece-via-tender-offer-124-midcap-radar.webp "CNBC-TV18")
⏲ 1 minute 51 seconds 👁 937
_ajanta-pharma-ltd-agile-pharma-operations-124-vector-consulting-group.webp "Vector Consulting Group")
⏲ 8 minutes 56 seconds 👁 25.5K
_alkhidmat-banoqabil-pharmacist-test.jpg)
_ajanta-pharma-buyback-2024124-profit-calculation-124-ajanta-pharma-share-news-124-latest-buyback-news.jpg)
_top-2-pharma-midcap-stocks-124-ca-rachana-ranade.jpg)
_ajanta-pharma-share-news-today-ajanta-pharma-share-news-124-ajanta-pharma-share-124-26th-april-2024.jpg)
_ajanta-pharma-ltd-q4-fy2023-24-earnings-conference-call.jpg)
_ajanta-pharma-what-makes-it-special.jpg)
_ajanta-pharma-approves-315-crore-share-buyback-at-1425-apiece-via-tender-offer-124-midcap-radar.jpg)
_ajanta-pharma-ltd-agile-pharma-operations-124-vector-consulting-group.jpg)
![[+]](/images/menu.gif){kind=small}